Taly Spivak-Kroizman

Title: Taly Spivak-Kroizman: Innovator in Adaptor Protein Research

Introduction

Taly Spivak-Kroizman is a notable inventor based in Rishon LeZiyyon, Israel. He has made significant contributions to the field of molecular biology, particularly in the study of adaptor proteins. With a total of two patents to his name, his work has implications for understanding cellular processes and potential medical applications.

Latest Patents

One of Taly's latest patents is focused on the adaptor protein FRS2 and related products and methods. This invention pertains to a newly identified adaptor protein that links protein kinases to activating partners within cells. The patent also covers nucleic acid molecules that encode portions of FRS2, nucleic acid vectors containing these molecules, and recombinant cells that house such vectors. Additionally, it includes polypeptides purified from these recombinant cells, antibodies to these polypeptides, and methods for identifying compounds that can enhance or inhibit FRS2 interactions with its natural binding partners. Furthermore, the patent outlines methods for diagnosing abnormal conditions in organisms using FRS2-related molecules or compounds.

Career Highlights

Taly Spivak-Kroizman is affiliated with New York University, where he continues to advance his research in the field of adaptor proteins. His work has garnered attention for its potential applications in both basic research and clinical settings.

Collaborations

Taly has collaborated with notable colleagues, including Haruhiko Kouhara and Irit Lax, who contribute to the innovative research environment surrounding his work.

Conclusion

Taly Spivak-Kroizman's contributions to the field of adaptor proteins, particularly through his patents on FRS2, highlight his role as an influential inventor in molecular biology. His ongoing research at New York University promises to further enhance our understanding of cellular mechanisms and their implications for health.